From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Tom Winnifrith Bearcast 2 Feb - why we are buying BP today at 335p

By Tom Winnifrith | Tuesday 2 February 2016


Disclosure: Financial Investigative Media Limited, which is not owned by Tom Winnifrith but by a trust for his dependants, owns shares in companies mentioned in this article. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


I have won £5 from Shipston's Buffett for tracking down a long lost cousin to whom he has not spoken in 50 years. That is my main achievment today. I shall comment on InternetQ (INTQ) and MX Oil (MXO) elsewhere. I start with a look at BP (BP.) and explain why we have bought the shares today. Then I look at Corero (CNS) in detail and at Condor Gold (CNR), Nighthawk (HAWK), Petroceltic (PCI), Mosman (MSMN) and Aureus (AUE) before a detailed look at the dog Blur (BLUR).


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

Gold

Sprott bullish on gold

 

SOS

Sosandar: when is the warning?

 

SCGL

Evil Banksta: TW schoolboy error

 

ARB

Worthless Argo what news Helios?

Sunday »

Bearcast

Tom Winnifrith Bearcast: macrobabble calls

 

AAU

Gold up Ariana down

Saturday »

AVCT

Cassava, A warning to Avacta Sharehoders 

Friday »

ALU

Alumasc Group – a growth Buy

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

 

APH

Alliance Pharma – a recovery Buy?

Time left: 08:59:47